Mapeo Cuartos Fríos OMS
Mapeo Cuartos Fríos OMS
Mapeo Cuartos Fríos OMS
Qualification of
temperature-controlled
storage areas
Technical supplement to
WHO Technical Report Series, No. 961, 2011
Annex 9: Model guidance for the storage and transport of time- and
temperature-sensitive pharmaceutical products
May 2015
3
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Abbreviations
CAPA corrective and preventive action (procedures)
EDLM electronic data logging monitor
IATA International Air Transport Authority
IQ installation qualification
OQ operational qualification
PDA Parenteral Drug Association
PQ performance qualification
SMS short message service
SOP standard operating procedure
TTSPP time- and temperature-sensitive pharmaceutical product
UPS uninterrupted power supply
4
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
Acknowledgements
The author of this document is Jean Bedard MBA , Infitrak Inc.
5
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Glossary
Auxiliary equipment: Equipment mostly used in conjunction with the equipment
to be qualified but not included in the qualification package.
Component: Any major piece, part or assembly of the main equipment or sub-
equipment that does not have its own power supply and could not operate as a
stand-alone unit (e.g. valves and switches).
Controller, critical: A controller for which control has a direct impact on the
quality of the product or proper operation of the equipment.
Controller, non-critical: A controller for which control has no direct impact on
the quality of the product or proper operation of the equipment.
Controller: A device that interprets a mechanical, digital or analogue signal,
generated by a sensor, to control an equipment or component.
Design qualification: The process of obtaining and documenting evidence
that the premises, equipment and supporting systems and processes have
been designed in accordance with the requirements for good manufacturing
practices (GMP).1
Deviation: For installation qualification: any discrepancy between the installation
specifications and the actual (as found) installation. For operational qualification:
any discrepancy between the protocol and the actual performed test, test function
methodology, testing equipment, and testing material.
Electronic data logging monitor (EDLM): A small portable device that measures
and stores temperature readings at predetermined time intervals by means of
an electronic sensor. These monitors have programmable alarm capabilities,
integrated displays, and can create reports and graphs which may be permanently
stored, shared and analysed via proprietary hardware, software, desktop
application or through hosted databases.
Installation qualification (IQ): The process of obtaining and documenting
evidence that the premises, equipment and supporting systems have been
provided and installed in compliance with their design specifications.
Main equipment: Major equipment to be qualified.
Operational qualification (OQ): The process of obtaining and documenting
evidence, under controlled conditions, that the premises, equipment and
supporting systems operate in accordance with their design specifications.
World Health Organization. WHO good manufacturing practices for pharmaceutical products: main
1
principles. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: forty-fifth report.
Geneva: World Health Organization; 2011: Annex 3 (WHO Technical Report Series, No. 961).
6
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
Definition from WHO/QAS/08.252 Rev 1 Sept 2009. Proposal for revision of WHO good distribution practices
2
Parenteral Drug Association (PDA). Technical Report No. 39: Guidance for temperature controlled
3
medicinal products: Maintaining the quality of temperature-sensitive medicinal products through the
transportation environment. Bethesda (MD): PDA; 2007.
8
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
1. Introduction
This Technical Supplement has been written to amplify the recommendations
given in section 4.7 of WHO Technical Report Series No. 961, 2011, Annex 9:
Model guidance for the storage and transport of time- and temperature-sensitive
pharmaceutical products.4 It covers the three stages of qualification needed before
the release of a temperature-controlled storage area for routine use: installation
qualification (IQ), operational qualification (OQ) and performance qualification
(PQ). Related topics are covered in the following Technical Supplements:
■■ Checking the accuracy of temperature control and monitoring devices
■■ Qualification of shipping containers
■■ Qualification of temperature-controlled road vehicles
■■ Temperature and humidity monitoring systems for fixed storage areas
■■ Temperature mapping of storage areas.
What is qualification?
In the context of this series of Technical Supplements, qualification is an
inspection and testing process used to establish that a piece of equipment
or a physical installation is fit for purpose in the operational context within
which it will be used. There are typically three stages in the process. Each
stage must be fully completed before the next one begins.
Stage 1 (for equipment): Establish by laboratory testing under tightly
controlled conditions that a specific item of equipment performs in
accordance with the user requirements specification (URS). This is design
qualification. Although design qualification demonstrates compliance with
the URS and associated test protocols, it does not prove that the equipment
will be suitable in a specific operating environment because the URS and the
test procedures are unlikely to reflect the full range of operating conditions.
Stage 1 (for installations): Establish by documented inspection and testing
that an installation 5 that has been assembled in a specific location is fully
in accordance with the URS and installation drawings. This is installation
qualification.
5
http://apps.who.int/medicinedocs/documents/s18683en/s18683en.pdf
4
The installation will typically incorporate components that have a design qualification.
5
9
WHO Expert Committee on Specifications for Pharmaceutical Preparations
1.1 Requirements
Every new temperature-controlled store must be qualified before it is released for
the routine storage of time- and temperature-sensitive pharmaceutical products
(TTSPPs). As a minimum, the qualification procedure should:
■■ Establish that the installation, including all associated control,
monitoring and alarm systems, has been carried out in accordance
with the relevant drawings and specifications.
■■ Demonstrate, through temperature mapping, that air temperatures
throughout the zone(s) designated for TTSPP storage are within
the specified limits, both when empty and when in the normal
loaded condition.
■■ Define zones which should not be used for storage of TTSPPs (for
example areas in close proximity to cooling coils, cold air streams or
heat sources).
■■ Demonstrate the time taken for temperatures to exceed the
designated limits in the event of power failure, and the time taken to
re-establish these limits following power restoration.
■■ Demonstrate the time taken for temperatures to return to within the
designated limits following a representative door opening event.
Further qualification exercises should be conducted whenever significant
modifications are made to the installation, or to the way in which it is used.
The qualification process must be fully documented in order to demonstrate
compliance to management, clients and regulatory authorities.
Qualification activities should be planned and documented. The plan
should set out the sequence of testing activities to be carried out. It should also
describe the method(s) for ensuring traceability between the individual test
activities and the specific design features being tested.
10
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
1.2 Objectives
This Technical Supplement applies to fixed storage locations used for TTSPP
logistic operations. The objective is to provide guidance on how to carry out the
three types of qualification needed to meet the requirements of good storage
practice in temperature-controlled areas. These are IQ, OQ and PQ.
11
WHO Expert Committee on Specifications for Pharmaceutical Preparations
2. Guidance
The purpose of qualification in the pharmaceutical and medical sector is to ensure
that equipment or ancillary systems are properly installed, work correctly, and
produce the specified performance outcomes under routine operating conditions.
■■ Identify the storage area and the equipment and systems required
for it to operate correctly and establish that all systems are installed
as specified.
■■ Ensure that an effective preventive maintenance programme is
in place.
14
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
15
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Table 1
Example of a standard template for recording approvals and changes to a document
Version history
16
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
2.3.6 Procedures
The protocol for a specific installation should describe the procedure for every
relevant test or check in detail, as follows:
a. Title: Briefly describe the test or check.
b. Target: Name the target system, subsystem or component.
c. Procedure: Clearly describe the test or check procedure as a
step‑by‑step process. Specify any associated materials or test
equipment required.
d. Acceptance: Define the acceptance criteria.
e. Data collection: Include templates for all the data collection
and test sheets required.
A generic set of IQ, OQ and PQ tests and checks is outlined in sections
2.4 to 2.7.
17
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Table 2
Example of an IQ inspection and test table
See Technical Supplement: Temperature and humidity monitoring systems for storage areas.
7
See Technical Supplement: Refrigeration equipment maintenance for a list of cold room enclosure checks.
8
19
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Table 2 continued
Subsystem or component inspection and test table
Details: Specified As found Pass or fail
Manufacturer: ABC refrigeration ABC refrigeration Pass
Model: TTW50 TTW40 Fail
Serial number: Not specified TTW40-1310-025 Fail
Internal ID number: CR1/RFU01 CR1/RFU01 Pass
Deviation report ref: DEV/001
Enter “none” if no deviation
Inspected by: AG Date: 27 Oct 2013
Checked by: JB Date: 5 Nov 2013
Table 3
Overall compliance check for electrical installation
21
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Once the overall compliance check has been completed, the electrical
supply to the individual critical components needs to be checked. The example
below relates to the example in Table 2.
Table 4
Electrical installation: critical component checks
22
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
The service panel and circuit-breakers that apply to the various critical
components should be clearly labelled both at the service panel itself and at
the component.
Table 5
Environmental conditions, control and monitoring checks
23
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Table 6
Equipment file index
TS, technical specifications; OI, operating instructions; MI, maintenance instructions; RS, recommended spare
parts list.
24
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
Do not begin the OQ stage until all relevant deviations recorded during the
IQ inspection have been corrected.
The purpose of OQ is to establish that the installation and all its systems and
subsystems operate effectively and consistently when the storage area is empty.
As soon as the OQ process has been completed and the installation has been
approved, the next step is the PQ stage, with the storage area fully operational.
Once the entire OQ and PQ process has been successfully completed, the
installation can be signed off and fully released for routine operation.
An OQ inspection should cover the following:
■■ Check the calibration of all temperature measuring and controlling
systems and components.
■■ Test the installation’s control systems and check that these systems
function correctly. Check the system set points.
■■ If there is a temperature alarm system, set the low and high alarm
limits and set-up and test the relevant alarm outputs such as email
messages, short message service (SMS) text messages and telephone
contacts. Record the results.
■■ Carry out a temperature mapping of the empty storage area and
record the results. See Technical Supplement: Temperature mapping
of storage areas.
25
WHO Expert Committee on Specifications for Pharmaceutical Preparations
■■ Ensure that all relevant SOPs are available, that the relevant
personnel have been trained to follow these SOPs and that training
records are kept.
Table 7
Alarm system test sheet
27
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Table 8
Test data sheet: temperature distribution
Data logger Min. temp. Max temp. Mean Within Inspected Date
ID number recorded recorded temp. range? by
(°C) (°C) (°C)
Yes No
DL-001
DL-002
DL-003
DL-004
DL-005
DL-006
DL-007
DL-XXX
Mapping period starts at (date/hour):
Mapping period ends at (date/hour):
Checked by: Date:
The temperature mapping supplement recommends that mapping should be carried out in both the
9
hottest and coldest months. However, for the purpose of OQ, only one mapping exercise is required.
28
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
In settings with unreliable electricity supplies, holdover is an important performance feature of mains-
10
powered freezers and refrigerators. For WHO prequalified vaccine refrigerators, the holdover time is
laboratory tested and reported. See the WHO PQS website at: http://apps.who.int/immunization_
standards/vaccine_quality/pqs_catalogue/
29
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Table 9
Power failure test sheet
DL-XXX
Power turned off at (hh:mm):
Power turned on at (hh:mm):
Checked by: Date:
■■ Make sure that all of the sections included in the OQ protocol have
been completed, signed and dated.
■■ Record all deviations from the installation drawings and
specifications in the deviation report section. Make sure that each
deviation is cross-referenced to the relevant sections of the OQ
protocol.
■■ Transcribe any handwritten notes made by the OQ team into the
relevant sections of the report.
30
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
Do not begin the PQ stage until all of the deviations recorded during the
OQ inspection have been corrected.
The purpose of PQ is to establish that the installation and all its systems and
subsystems operate effectively and consistently when the storage area is fully
operational (in use, loaded with TTSPPs). PQ is normally carried out immediately
after satisfactory completion of the IQ and OQ stages. As previously noted, once
the entire OQ and PQ process has been successfully completed and all deviations
have been corrected, the installation can be signed off and fully released for
routine operation.
A PQ inspection should:
■■ Check that all controllers and sensors are correctly calibrated.
■■ Carry out a temperature mapping of the storage area loaded as in
normal operations. Record the results. See Technical Supplement:
Temperature mapping of storage areas.
■■ Test and record temperature recovery following a door opening
during normal operation.
31
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Table 10
Door opening test sheet
DL-001
DL-002
DL-003
DL-004
DL-005
DL-006
DL-007
DL-XXX
32
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
Table 10 continued
Door(s) opened at (hh:mm):
Door(s) closed at (hh:mm):
Checked by: Date:
The installation cannot be formally released for routine use until all of the
deviations recorded during the PQ inspection have been corrected.
11
Domestic refrigerators do not control temperature accurately and WHO specifically recommends that they
should not be used for storing vaccines, many of which are damaged by freezing.
12
See the WHO PQS website at:
http://apps.who.int/immunization_standards/vaccine_quality/pqs_catalogue/
33
WHO Expert Committee on Specifications for Pharmaceutical Preparations
34
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
Bibliography
■■ Cloud PA. Pharmaceutical equipment validation: The ultimate qualification
guidebook. Englewood (CO): Interpharm Press; 1998.
■■ Health Canada (Health Products and Food Branch Inspectorate). Good
manufacturing practices (GMP), Guidelines – 2009 edition, version 2,
GUI‑0001
(http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/compli-conform/gmp-
bpf/docs/gui-0001-eng.pdf, accessed 10 February 2015).
■■ Health Canada (Health Products and Food Branch Inspectorate). Guide 0069,
Guidelines for temperature control of drug products during storage and
transportation. 2005 (http://www.rxcritical.ca/pdf/Guide-0069.pdf).
■■ Parenteral Drug Association. Technical Report No. 39: Guidance for
temperature controlled medicinal products: Maintaining the quality of
temperature-sensitive medicinal products through the transportation
environment. Bethesda (MD): Parenteral Drug Association; 2007
(https://store.pda.org/ProductCatalog/Product.aspx?ID=1270, accessed 10
February 2015).
■■ United States Pharmacopeia (USP): Chapter 1079: Good storage and
shipping practices. Rockville (MD); USP
(https://mc.usp.org/sites/default/files/documents/GeneralChapterPDFs/
c1079%20USP36.pdf, accessed 10 February 2015).
■■ US Food and Drug Administration (US FDA). Title 21 --Food and drugs
chapter I--Food and Drug Administration Department of Health and
Human Services Subchapter H--medical devices. Part 820: Quality system
regulation. Silver Spring (MD): US FDA
(http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.
cfm?CFRPart=820, accessed 10 February 2015).
■■ US Food and Drug Administration (US FDA). Title 21--Food and drugs
chapter I--Food and Drug Administration Department of Health and
Human Services Subchapter C--drugs: general. Part 210--Current good
manufacturing practice in manufacturing, processing, packing, or holding of
drugs; general. Silver Spring (MD): US FDA
(http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.
cfm?CFRPart=210, accessed 10 February 2015).
35
WHO Expert Committee on Specifications for Pharmaceutical Preparations
■■ US Food and Drug Administration. Title 21--Food and Drugs Chapter I--
Food and Drug Administration Department of Health and Human Services
Subchapter C--Drugs: General – Part 211: Current Good Manufacturing
Practice for Finished Pharmaceuticals. Silver Spring (MD): US FDA
(http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.
cfm?CFRPart=211, accessed 10 February 2015).
■■ World Health Organization. Model guidance for the storage and transport
of time- and temperature-sensitive pharmaceutical pharmaceuticals. In:
WHO Expert Committee on Specifications for Pharmaceutical Preparations:
forty-fifth report. Geneva: World Health Organization; 2011: Annex 9
(WHO Technical Report Series, No. 961; http://apps.who.int/medicinedocs/
documents/s18683en/s18683en.pdf, accessed 10 February 2015).
36
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
Revision history
Date Change summary Reason for change Approved
37
WHO Expert Committee on Specifications for Pharmaceutical Preparations
Annex 1
Deviation and corrective action report form
Report number:
DEVIATION DESCRIPTION
38
WHO Technical Report Series, No. 992, Annex 5
Supplement 7
39